| CXHL1501574 | ZL-2102胶囊 | ZL-2102 | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-08-24 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-04-17 | view |
| CXHL1501571 | ZL-2102 | ZL-2102 | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-08-24 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-04-17 | view |
| CXHL1501572 | ZL-2102胶囊 | ZL-2102 | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-08-24 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-04-17 | view |
| CXHL1501573 | ZL-2102胶囊 | ZL-2102 | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-08-24 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-04-17 | view |
| CXHL1600122 | ZL-2303片 | olmutinib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-07-17 | view |
| CXHL1600123 | ZL-2303片 | olmutinib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-07-17 | view |
| CXHL1600121 | ZL-2303盐酸盐 | olmutinib hydrochloride | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-07-17 | view |
| CXHL1600144 | 丙氨酸布立尼布 | brivanib alaninate | Active ingredient | Chemical Drugs(1) | New Drug Application | 2016-07-15 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-03-07 | view |
| CXHL1600146 | 丙氨酸布立尼布片 | brivanib alaninate | Tablet | Chemical Drugs(1) | New Drug Application | 2016-07-15 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-03-07 | view |
| CXHL1600344 | ZL-2306胶囊 | niraparib tosylate | Capsule | Chemical Drugs(1) | New Drug Application | 2017-03-01 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-07-24 | view |
| CXHL1700045 | ZL-2302 | ZL-2302 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2017-03-31 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | Certificate Issued | 2017-10-17 | view |
| JXHL1900112 | 注射用ETX2514SUL | ETX2514SUL | Lyophilized | Chemical Drugs(1) | Import Drug Application | 2019-05-22 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-05-21 | view |
| CXHB1900068 | ZL-2306胶囊 | niraparib tosylate | Capsule | Chemical Drugs | Supplementary Application | 2019-11-15 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-14 | view |
| JXSL1900118 | INCMGA00012注射液 | retifanlimab | Injection | Biological Products | Import Drug Application | 2019-11-16 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-15 | view |
| JXSL1900115 | Margetuximab注射液 | margetuximab | Injection | Biological Products | Import Drug Application | 2019-11-16 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-15 | view |
| JXSL1900114 | MGD013注射液 | tebotelimab | Injection | Biological Products | Import Drug Application | 2019-11-16 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-15 | view |
| JXSL1900113 | Margetuximab注射液 | margetuximab | Injection | Biological Products | Import Drug Application | 2019-11-16 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-15 | view |
| JXSL1900119 | INCMGA00012注射液 | retifanlimab | Injection | Biological Products | Import Drug Application | 2019-11-16 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-15 | view |
| JXSL1900116 | MGD013注射液 | tebotelimab | Injection | Biological Products | Import Drug Application | 2019-11-28 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-27 | view |
| CXHL1900376 | 甲苯磺酸尼拉帕利胶囊 | niraparib tosylate | Capsule | Chemical Drugs(1) | New Drug Application | 2019-11-29 | 再鼎医药（上海）有限公司 | Zai Lab (Shanghai) Co Ltd | In Review | 2019-11-28 | view |
